FDA Inspection 752730 — Prescript Pharmaceuticals, Inc.

Prescript Pharmaceuticals, Inc. — FEI 1000135824

The FDA completed an inspection of Prescript Pharmaceuticals, Inc. on November 16, 2011 in Pleasanton, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 6 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
November 16, 2011
Fiscal Year
2012
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Pleasanton, CA (United States)

Citations

IDCFRDescription
127021 CFR 211.68(b)input/output verification
127421 CFR 211.68(a)Calibration/Inspection/Checking not done
191421 CFR 211.166(a)Lack of written stability program
363021 CFR 211.170(b)Drug product reserve containers
434221 CFR 211.142(b)Storage under appropriate conditions
439121 CFR 211.180(e)(2)Items to cover on annual reviews